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makes CpG islands ideal sequences for 
easy access by transcription activators 
and RNA Pol II complexes, hence their 
prevalent use in the promoters of house-
keeping genes in mammals. Previously, 
poly (dA:dT) tracts in the yeast genome 
were shown to have similar molecular 
properties and transcriptional activat-
ing functions (Anderson and Widom, 
2001; Iyer and Struhl, 1995). It appears 
that some CpG promoters have evolved 
to regulate rapid signal-induced tran-
scription in response to diverse stimuli. 
This requires a signal-induced activa-
tor, which converts pre-engaged RNA 
Pol II into a form that can efficiently 
undergo transcription elongation cou-
pled to RNA splicing. Thus, to end with 
the golfing analogy, CpG islands are 
the “transcriptional tee off” areas of 
the mammalian genome that provide a 
nucleosome-depleted surface for the 
efficient assembly and partial activation 
of RNA Pol II complexes prior to their 
productive launch down genomic “fair-
ways” in a signal-dependent manner.
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Many genes are toxic when overexpressed, but general mechanisms for this toxicity have proven 
elusive. Vavouri et al. (2009) find that intrinsic protein disorder and promiscuous molecular inter-
actions are strong determinants of dosage sensitivity, explaining in part the toxicity of dosage-
sensitive oncogenes in mice and humans.In yeast, approximately 15%–20% of 
genes are toxic when overexpressed 
(Gelperin et al., 2005; Sopko et al., 
2006), a phenomenon known as dosage 
sensitivity. A similar fraction of genes 
are known to be essential for growth 
in standard laboratory conditions and 
can lead to cell death upon deletion or 
downregulation (Giaever et al., 2002). 
Too much expression of a gene is not the 
same as too little, and it is not surprising 
that the mechanisms of toxicity appear 
quite different. What has been surpris-
ing is that a general understanding is 
emerging for the causes of cell death 
stemming from loss of function but not 
from overexpression. In the case of loss 
of function, essential genes tend to pref-16 Cell 138, July 10, 2009 ©2009 Elsevier Incerentially interact with each other, both 
as hubs in gene networks and as com-
ponents of essential protein complexes 
(Figure 1). If any one component of an 
essential complex is deleted, the whole 
system fails. This trend explains a large 
fraction of the cases in which reducing 
or abolishing expression of a particular 
gene results in lethality (Hart et al., 2007; 
Wang et al., 2009). In contrast, dosage 
sensitivity has thus far eluded any such 
general explanation. One is now pro-
vided, at least in part, by Vavouri et al. 
(2009) in this issue.
This notable lack of a general mecha-
nism for dosage sensitivity has been a 
source of considerable frustration given 
its contribution to many diseases, includ-.ing a wide variety of amyloid, prion, and 
other diseases of protein misfolding and 
aggregation. For example, one of the 
first mouse models to develop the pre-
dominant features of Alzheimer’s disease 
entails overexpressing a variant of the 
human amyloid precursor protein (Games 
et al., 1995). Overexpression of dosage-
sensitive oncogenes also leads to a vari-
ety of human cancers. For example, it has 
recently been shown that overexpres-
sion (up to 100-fold) of the angiotensin II 
receptor type I enables a highly invasive 
phenotype in mammalian epithelial cells, 
thereby defining a subpopulation of breast 
cancers (10%–20%) that might respond 
to treatment with angiotensin receptor 
antagonists (Rhodes et al., 2009). A better 
notion of why some genes are 
toxic when overexpressed and 
others are not might therefore 
help in understanding mecha-
nisms of disease progression 
and even in designing new 
therapeutics.
In order to search for general 
mechanisms of dosage sensi-
tivity, Vavouri and colleagues 
tested a variety of likely factors, 
including protein abundance, 
aggregation potential, half-life, 
and the degree to which codon 
usage is optimized for protein 
translation, all of which failed 
to provide a reliable prediction 
(Vavouri et al., 2009). Instead 
the strongest predictors of 
dosage sensitivity are intrinsic 
protein disorder and the ten-
dency to participate directly in 
large numbers of pairwise pro-
tein-protein interactions. The 
latter is especially predictive 
when either partner contains 
functional motifs completely 
contained in a single linear 
stretch of amino acids. These 
factors do not explain all (or 
even most) of the trend—this is 
clearly only part of the story. Nonetheless 
these factors provide successful predic-
tions of dosage-sensitive genes in yeast 
and metazoans, to the extent that a com-
puter algorithm trained to identify such 
proteins correctly predicts the dosage tox-
icity of 6 of 8 genes tested in worms.
One interpretation, offered by Vavouri 
et al., is that intrinsically disordered pro-
teins are more likely to participate in pro-
miscuous protein interactions when over-
expressed, simply as a consequence of 
mass action. This explanation draws sup-
port from two intriguing sets of contrast-
ing observations: First, dosage-sensitive 
genes show higher numbers of direct pro-
tein interactions (measured by the yeast 
two-hybrid assay) than dosage-insensitive 
genes but interestingly do not share more 
interaction partners in protein complexes 
(as measured by affinity purification or 
coimmunoprecipitation). This is in strong 
contrast to genes essential upon knock-
out or knockdown (Figure 1) and suggests 
that there is something special about the 
excess participation specifically in pairwise 
interactions. Conceivably, the yeast two-
hybrid assay might preferentially detect 
interactions that result from non-native 
expression of highly interactive (or even 
just sticky) proteins; the assay requires 
constitutive nuclear expression of proteins 
whose native expression is neither consti-
tutive nor nuclear, and in fact, hub proteins 
in yeast two-hybrid interaction networks 
are known to exhibit increased disorder 
(Haynes et al., 2006). Nonetheless, the sig-
nal for dosage sensitivity appears stronger 
than this trend alone. Second, dosage-
sensitive proteins show increased intrinsic 
disorder, but not increased tendencies to 
self-aggregate, at least as predicted com-
putationally. Thus, dosage sensitivity does 
not appear to be predominantly driven by 
self-aggregation, although it is possible 
that this trend might be overturned with 
direct experimental data. Nonetheless, 
such aggregation would still be consis-
tent with the notion of mass-action-driven 
interaction promiscuity being a major 
determinant of dosage sensitivity.
This model in which increased dos-
age drives toxic interactions by mass 
action—tested in yeast, flies, and 
worms—might also explain a 
fraction of dosage-sensitive 
oncogenes in humans and 
mice. These cases abound in 
the literature, especially for 
oncogenic transcription fac-
tors, such as the gene Oct-4. 
Oct-4 is a homeobox gene 
responsible for maintaining 
pluripotency in embryonic 
stem cells. Strikingly, as the 
expression level of Oct-4 
is varied from 0% to 150% 
relative abundance, the inci-
dence of tumors formed fol-
lowing injection into synge-
neic mice varies from 4% to 
64%–83%, an effect possibly 
stemming from promiscuous 
activation of growth factors 
(Gidekel et al., 2003). Vavouri 
et al. systematically analyze 
a set of dosage-sensitive 
oncogenes. They show that 
genes known to be ampli-
fied and causally linked to 
cancer tend to encode pro-
teins that are enriched with 
intrinsically disordered seg-
ments, contain or bind linear 
functional motifs, and make 
many direct pairwise physical interac-
tions with other proteins. Thus, at least 
a substantial portion of these genes are 
consistent with the model.
Intrinsic disorder and protein-pro-
tein interaction promiscuity account 
only for a portion of dosage-sensi-
tivity cases. This begs the question 
of what accounts for the rest of the 
cases? A test of the dosage-sensitive 
yeast genes assembled by Vavouri et 
al. shows that the 839 dosage-sen-
sitive genes are strongly statistically 
enriched for proteins with transcrip-
tion factor and DNA-binding activities 
(p ≤ 10−10; hypergeometric probability), 
with 110 of the proteins involved in 
some aspect of transcriptional regula-
tion. The set is enriched for many other 
regulatory functions as well, includ-
ing 50 genes known to participate in 
phosphorylation, dephosphorylation, 
or autophosphorylation, and 30 in RNA 
transport. Thus, the notion of mass-
action-driven protein interaction pro-
miscuity can probably be generalized 
to mass-action-driven promiscuity of 
figure 1. Too Much Gene expression Is not the same as Too Little
(A) Genes that lead to cell death or growth defects upon knockout or knock-
down tend to preferentially associate with each other in the same protein 
complexes, shown here by representing proteins as circles and protein-pro-
tein associations by lines forming a network of protein interactions. Com-
plexes of essential proteins tend to contain more protein constituents than 
nonessential complexes. These trends explain a large fraction (>30%) of the 
essential genes in yeast cells (Hart et al., 2007; Wang et al., 2009).
(B) In contrast to genes that are essential upon knockout or knockdown, a dif-
ferent mechanism appears to underlie the toxicity observed upon gene over-
expression (Vavouri et al., 2009). Such dosage-sensitive genes tend to partici-
pate in larger numbers of direct pairwise protein interactions, shown here with 
dosage-sensitive genes forming hubs in a network of yeast two-hybrid protein 
interactions. Dosage-sensitive genes also tend to be intrinsically disordered, 
as illustrated by the dashed line for the protein structure pictured in the inset. 
Overexpression of an intrinsically disordered protein may increase its already 
high degree of interaction promiscuity, leading to toxic partnerships and det-
rimental effects on the cell.Cell 138, July 10, 2009 ©2009 Elsevier Inc. 17
many types of macromolecular interac-
tions, including transcription factor-tar-
get interactions, kinase/phosphatase-
target interactions, and so on. Vavouri 
et al. point out a prime candidate for 
overexpression-induced promiscuity 
leading to toxicity, overexpression of 
microRNAs, which might lead to many 
off-target gene regulatory interactions. 
Therefore, although the current data 
primarily implicate promiscuous protein 
interactions and disordered proteins, a 
broader exploration of regulatory pro-
miscuity may yet reveal mechanisms 
of dosage sensitivity with even greater 
predictive value.18 Cell 138, July 10, 2009 ©2009 Elsevier Inc
Animals constantly fine-tune their pro-
files of gene expression in order to adapt 
to the physical demands of the environ-
ment and to the availability of nutrients, 
be it feast or famine. Moreover, differ-
ent cell types vary in their metabolic 
and gene expression requirements. In 
a recent issue of Science, Wellen et al. 
(2009) provide evidence for a mecha-
nism in mammalian cells that links the 
production of acetyl-CoA from citrate 
to the regulation of metabolic genes 
through alterations in histone acetyla-
tion. These findings illustrate how central 
metabolism, too often viewed as a sub-
ject for textbooks, still conceals plenty of 
surprises.
Under normal circumstances, most 
adult cells utilize available nutrients effi-
ciently, primarily for energy production. 
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This situation is markedly different in 
cells that grow rapidly or that metabo-
lize nutrients quickly, such as in the 
fetus, during cellular insults (such as 
extensive DNA damage) or in tumors. 
Cancer cells, in particular, become very 
adept at balancing the need for energy 
production with anabolic processes, 
such as the increased synthesis of lip-
ids, nucleic acids, and proteins. Otto 
Warburg’s hypothesis (Warburg, 1956; 
Hsu and Sabatini, 2008) that cancer 
cells tweak their metabolic pathways in 
favor of aerobic glycolysis has largely 
been validated experimentally, includ-
ing the recent identification of pyruvate 
kinase isoforms that help to switch glu-
cose metabolism from the production of 
CO2 to anabolic growth (Christofk et al., 
2008).
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teomics 8, 1361–1381.Cells maintain this metabolic bal-
ancing act by integrating the control of 
gene expression with metabolism and 
by compartmentalization between mito-
chondria (for energy generation), the 
cytoplasm (for biomolecule production), 
and the nucleus (for gene expression). 
Although this division of labor promotes 
efficiency in dealing with available nutri-
ents, the system needs to be able to 
reshuffle its global activities to meet the 
increased energy demands of growing 
cells. Growth factors stimulate cells to 
take up more nutrients by changing gene 
expression patterns, a process which 
is promoted by shuttling transcription 
factors into the nucleus or by activating 
signaling kinases, for example. In addi-
tion, it is now clear that in order to run 
the whole system of metabolic control 
center stage
 modulate gene expression. A 
ose metabolism alter the avail-
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